welcome
Reuters

Reuters

Health

Health

Amgen to expand Ohio biotech manufacturing plant

Reuters
Summary
Nutrition label

81% Informative

Amgen announces $900 million expansion of its Ohio biotech manufacturing facility.

Amgen is the latest in a string of drugmakers pledging to increase U.S. capacity amid Trump administration threats of potential import tariffs.

Other drugmakers committing recently to US manufacturing expansions include Eli Lilly , Novartis , Roche , and Johnson & Johnson .

VR Score

90

Informative language

95

Neutral language

73

Article tone

formal

Language

English

Language complexity

70

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links